Affordable Access

Publisher Website

Pre or post-operative medical treatment with nafarelin in stage III–IV endometriosis: a French multicenter study

Authors
Journal
European Journal of Obstetrics & Gynecology and Reproductive Biology
0301-2115
Publisher
Elsevier
Publication Date
Volume
79
Issue
2
Identifiers
DOI: 10.1016/s0301-2115(98)00028-1
Keywords
  • Endometriosis
  • Medico-Surgical Treatment
  • Clinical Trial
Disciplines
  • Medicine

Abstract

Abstract Objectives: To determine the effectiveness of a 6-month course of nafarelin in the treatment of stage III–IV endometriosis and to determine if pre-operative use of nafarelin facilitates surgery. Design: Prospective, multicenter, clinical trial. Setting: Eight university hospitals and two private practice institutions in France. Patients: Fifty-five patients with stage III and IV endometriosis. Two were excluded. Interventions: The severity of endometriosis was assessed at the time of laparoscopy and patients were randomized to have either laparosopic surgery at that time following 6 months of nafarelin therapy (n=28), or laparoscopic surgery following 6 months of nafarelin therapy (n=25). All had 200 μg intranasal nafarelin twice a day for 6 months and a second look laparoscopy. Main outcome measure: Clinical efficacy, tolerance to the treatment. Results: Efficacy and tolerance to the treatment were the same in both groups. AFS scores compared on both laparoscopies were significantly better if nafarelin was given prior to surgery (P=0.007). Conclusions: This preliminary study shows that in cases of combined medico-surgical treatment for stage III–IV endometriosis, preoperative medical treatment with GnRH-a gives a better AFS score improvement, but no conclusion was possible whether preoperative treatment facilitates surgery.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments